Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1995 May;63(5):1718–1724. doi: 10.1128/iai.63.5.1718-1724.1995

Endobronchial inflammation following Pseudomonas aeruginosa infection in resistant and susceptible strains of mice.

C Morissette 1, E Skamene 1, F Gervais 1
PMCID: PMC173215  PMID: 7729877

Abstract

The early endobronchial inflammation induced by Pseudomonas aeruginosa infection varies in resistant and susceptible strains of mice. Mice of the DBA/2 strain are severely afflicted by the infection, with a high bacterial burden accumulating rapidly following inoculation and a high mortality rate occurring. Mice of the BALB/c strain are resistant to infection and clear the bacteria within 3 to 7 days. Infection of (BALB/c x DBA/2)F1 hybrid mice showed that the resistance to lung P. aeruginosa infection is inherited as a dominant trait. Mice of the A/J and C57BL/6 strains were found to have an intermediate phenotype to Pseudomonas aeruginosa infection when compared with BALB/c and DBA/2 strains. The decrease in the bacterial load seen early after infection coincided with a steady and strong recruitment of inflammatory cells to the bronchoalveolar spaces of mice of the resistant BALB/c strain. On the other hand, the recruitment of inflammatory cells to the lungs of mice of the susceptible DBA/2 strain was deficient, resulting in the failure to control bacterial multiplication. Chemotactic factors, proinflammatory cytokines, and the number and function of recruited inflammatory cells may play major roles in the determination of the genetic resistance to lung infection with P. aeruginosa in a normal immunocompetent host.

Full Text

The Full Text of this article is available as a PDF (407.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baltimore R. S., Christie C. D., Smith G. J. Immunohistopathologic localization of Pseudomonas aeruginosa in lungs from patients with cystic fibrosis. Implications for the pathogenesis of progressive lung deterioration. Am Rev Respir Dis. 1989 Dec;140(6):1650–1661. doi: 10.1164/ajrccm/140.6.1650. [DOI] [PubMed] [Google Scholar]
  2. Berger M. Inflammation in the lung in cystic fibrosis. A vicious cycle that does more harm than good? Clin Rev Allergy. 1991 Spring-Summer;9(1-2):119–142. doi: 10.1007/978-1-4612-0475-6_8. [DOI] [PubMed] [Google Scholar]
  3. Berk R. S., Hazlett L. D. Further studies on the genetic control of murine corneal response to Pseudomonas aeruginosa. Rev Infect Dis. 1983 Nov-Dec;5 (Suppl 5):S936–S940. doi: 10.1093/clinids/5.supplement_5.s936. [DOI] [PubMed] [Google Scholar]
  4. Berk R. S., Leon M. A., Hazlett L. D. Genetic control of the murine corneal response to Pseudomonas aeruginosa. Infect Immun. 1979 Dec;26(3):1221–1223. doi: 10.1128/iai.26.3.1221-1223.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Buret A., Cripps A. W. The immunoevasive activities of Pseudomonas aeruginosa. Relevance for cystic fibrosis. Am Rev Respir Dis. 1993 Sep;148(3):793–805. doi: 10.1164/ajrccm/148.3.793. [DOI] [PubMed] [Google Scholar]
  6. Cerquetti M. C., Sordelli D. O., Bellanti J. A., Hooke A. M. Lung defenses against Pseudomonas aeruginosa in C5-deficient mice with different genetic backgrounds. Infect Immun. 1986 Jun;52(3):853–857. doi: 10.1128/iai.52.3.853-857.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cerquetti M. C., Sordelli D. O., Ortegon R. A., Bellanti J. A. Impaired lung defenses against Staphylococcus aureus in mice with hereditary deficiency of the fifth component of complement. Infect Immun. 1983 Sep;41(3):1071–1076. doi: 10.1128/iai.41.3.1071-1076.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Correlation between genotype and phenotype in patients with cystic fibrosis. The Cystic Fibrosis Genotype-Phenotype Consortium. N Engl J Med. 1993 Oct 28;329(18):1308–1313. doi: 10.1056/NEJM199310283291804. [DOI] [PubMed] [Google Scholar]
  9. Gervais F., Stevenson M., Skamene E. Genetic control of resistance to Listeria monocytogenes: regulation of leukocyte inflammatory responses by the Hc locus. J Immunol. 1984 Apr;132(4):2078–2083. [PubMed] [Google Scholar]
  10. Heidbrink P. J., Toews G. B., Gross G. N., Pierce A. K. Mechanisms of complement-mediated clearance of bacteria from the murine lung. Am Rev Respir Dis. 1982 May;125(5):517–520. doi: 10.1164/arrd.1982.125.5.517. [DOI] [PubMed] [Google Scholar]
  11. Johansen H. K., Espersen F., Pedersen S. S., Hougen H. P., Rygaard J., Høiby N. Chronic Pseudomonas aeruginosa lung infection in normal and athymic rats. APMIS. 1993 Mar;101(3):207–225. [PubMed] [Google Scholar]
  12. Johnston R. B., Jr The complement system in host defense and inflammation: the cutting edges of a double edged sword. Pediatr Infect Dis J. 1993 Nov;12(11):933–941. doi: 10.1097/00006454-199311000-00009. [DOI] [PubMed] [Google Scholar]
  13. Kerem E., Corey M., Kerem B. S., Rommens J., Markiewicz D., Levison H., Tsui L. C., Durie P. The relation between genotype and phenotype in cystic fibrosis--analysis of the most common mutation (delta F508). N Engl J Med. 1990 Nov 29;323(22):1517–1522. doi: 10.1056/NEJM199011293232203. [DOI] [PubMed] [Google Scholar]
  14. Koch C., Høiby N. Pathogenesis of cystic fibrosis. Lancet. 1993 Apr 24;341(8852):1065–1069. doi: 10.1016/0140-6736(93)92422-p. [DOI] [PubMed] [Google Scholar]
  15. Larsen G. L., Mitchell B. C., Harper T. B., Henson P. M. The pulmonary response of C5 sufficient and deficient mice to Pseudomonas aeruginosa. Am Rev Respir Dis. 1982 Aug;126(2):306–311. doi: 10.1164/arrd.1982.126.2.306. [DOI] [PubMed] [Google Scholar]
  16. Martin D. W., Schurr M. J., Mudd M. H., Govan J. R., Holloway B. W., Deretic V. Mechanism of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients. Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8377–8381. doi: 10.1073/pnas.90.18.8377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Mock B. A., Holiday D. L., Cerretti D. P., Darnell S. C., O'Brien A. D., Potter M. Construction of a series of congenic mice with recombinant chromosome 1 regions surrounding the genetic loci for resistance to intracellular parasites (Ity, Lsh, and Bcg), DNA repair responses (Rep-1), and the cytoskeletal protein villin (Vil). Infect Immun. 1994 Jan;62(1):325–328. doi: 10.1128/iai.62.1.325-328.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Ohno A., Miyazaki S., Tateda K., Kaneko Y., Huruya N., Tsuji A., Yamaguchi K., Goto S. [The study of pathogenic mechanisms of chronic Pseudomonas aeruginosa lung infections by mucoid strains]. Kansenshogaku Zasshi. 1992 Mar;66(3):407–415. doi: 10.11150/kansenshogakuzasshi1970.66.407. [DOI] [PubMed] [Google Scholar]
  19. Pedersen S. S. Lung infection with alginate-producing, mucoid Pseudomonas aeruginosa in cystic fibrosis. APMIS Suppl. 1992;28:1–79. [PubMed] [Google Scholar]
  20. Pennington J. E., Williams R. M. Influence of genetic factors on natural resistance of mice to Pseudomonas aeruginosa. J Infect Dis. 1979 Apr;139(4):396–400. doi: 10.1093/infdis/139.4.396. [DOI] [PubMed] [Google Scholar]
  21. Pier G. B., Saunders J. M., Ames P., Edwards M. S., Auerbach H., Goldfarb J., Speert D. P., Hurwitch S. Opsonophagocytic killing antibody to Pseudomonas aeruginosa mucoid exopolysaccharide in older noncolonized patients with cystic fibrosis. N Engl J Med. 1987 Sep 24;317(13):793–798. doi: 10.1056/NEJM198709243171303. [DOI] [PubMed] [Google Scholar]
  22. Pier G. B., Small G. J., Warren H. B. Protection against mucoid Pseudomonas aeruginosa in rodent models of endobronchial infections. Science. 1990 Aug 3;249(4968):537–540. doi: 10.1126/science.2116663. [DOI] [PubMed] [Google Scholar]
  23. Preston M. J., Kernacki K. A., Berk J. M., Hazlett L. D., Berk R. S. Kinetics of serum, tear, and corneal antibody responses in resistant and susceptible mice intracorneally infected with Pseudomonas aeruginosa. Infect Immun. 1992 Mar;60(3):885–891. doi: 10.1128/iai.60.3.885-891.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Santis G., Osborne L., Knight R. A., Hodson M. E. Independent genetic determinants of pancreatic and pulmonary status in cystic fibrosis. Lancet. 1990 Nov 3;336(8723):1081–1084. doi: 10.1016/0140-6736(90)92566-z. [DOI] [PubMed] [Google Scholar]
  25. Santis G., Osborne L., Knight R. A., Hodson M. E. Linked marker haplotypes and the delta F508 mutation in adults with mild pulmonary disease and cystic fibrosis. Lancet. 1990 Jun 16;335(8703):1426–1429. doi: 10.1016/0140-6736(90)91448-j. [DOI] [PubMed] [Google Scholar]
  26. Santis G., Osborne L., Knight R., Hodson M. E., Ramsay M. Genetic influences on pulmonary severity in cystic fibrosis. Lancet. 1990 Feb 3;335(8684):294–294. doi: 10.1016/0140-6736(90)90114-k. [DOI] [PubMed] [Google Scholar]
  27. Sordelli D. O., Cerquetti M. C., Bellanti J. A., Morris Hooke A. Specific pulmonary defences against Pseudomonas aeruginosa after local immunization with temperature-sensitive mutants. J Gen Microbiol. 1987 Oct;133(10):2835–2841. doi: 10.1099/00221287-133-10-2835. [DOI] [PubMed] [Google Scholar]
  28. Sordelli D. O., Cerquetti M. C., Morris Hooke A., Bellanti J. A. Effect of chemotactins released by Staphylococcus aureus and Pseudomonas aeruginosa on the murine respiratory tract. Infect Immun. 1985 Aug;49(2):265–269. doi: 10.1128/iai.49.2.265-269.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Sordelli D. O., Cerquetti M. C., el-Tawil G., Ramwell P. W., Hooke A. M., Bellanti J. A. Ibuprofen modifies the inflammatory response of the murine lung to Pseudomonas aeruginosa. Eur J Respir Dis. 1985 Aug;67(2):118–127. [PubMed] [Google Scholar]
  30. Sordelli D. O., Djafari M., García V. E., Fontán P. A., Döring G. Age-dependent pulmonary clearance of Pseudomonas aeruginosa in a mouse model: diminished migration of polymorphonuclear leukocytes to N-formyl-methionyl-leucyl-phenylalanine. Infect Immun. 1992 Apr;60(4):1724–1727. doi: 10.1128/iai.60.4.1724-1727.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Sordelli D. O., Zeligs B. J., Cerquetti M. C., Morris Hooke A., Bellanti J. A. Inflammatory responses to Pseudomonas aeruginosa and Staphylococcus aureus in the murine lung. Eur J Respir Dis. 1985 Jan;66(1):31–39. [PubMed] [Google Scholar]
  32. Starke J. R., Edwards M. S., Langston C., Baker C. J. A mouse model of chronic pulmonary infection with Pseudomonas aeruginosa and Pseudomonas cepacia. Pediatr Res. 1987 Dec;22(6):698–702. doi: 10.1203/00006450-198712000-00017. [DOI] [PubMed] [Google Scholar]
  33. Woods D. E., Sokol P. A., Bryan L. E., Storey D. G., Mattingly S. J., Vogel H. J., Ceri H. In vivo regulation of virulence in Pseudomonas aeruginosa associated with genetic rearrangement. J Infect Dis. 1991 Jan;163(1):143–149. doi: 10.1093/infdis/163.1.143. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES